| PUBCHEM ID |
71587649
|
| UNII |
230K0823CE
|
| Preferred Term |
DIPENTAERYTHRITYL TETRAHYDROXYSTEARATE/TETRAISOSTEARATE
|
| CAS |
220716-33-6
|
| INCHIKEY |
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CCCCCC[C@H](CCCCCCCCCCC(OC[C@](CO)(COC[C@@](CO)(COC(CCCCCCCCCCCCCCC(C)C)=O)COC(CCCCCCCCCC[C@@H](CCCCCC)O)=O)COC(CCCCCCCCCCCCCCC(C)C)=O)=O)O
|
| Total Surface Area |
1212,4
|
| Relative PSA |
0,12748
|
| TPSA |
195,35
|
| cLogS |
-16,979
|
| MW |
1352,14
|
| cLogP |
26,306
|
| H-Acceptors |
13
|
| H-Donors |
4
|
| Ro5 violations |
3
|
| Druglikeness |
-26,601
|
| DrugScore |
5,00021250985894E-02
|
| Mutagenic |
low
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,6499
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Non-substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
2,4166
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,3951
|
| Tetrahymena Pyriformis Toxicity |
High HBT
|
| Biodegradation |
Ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
1,9069
|
| Carcinogenicity (Three-class) |
Non-required
|
